Skip to main content
. 2018 Jul 12;12:201. doi: 10.3389/fncel.2018.00201

Figure 2.

Figure 2

Loss of Tsc1 in myelinating glia affects the myelination phase leading to axonal hypomyelination. (A,B) Immunostaining of cross cryosections of sciatic nerves from P15 Tsc1Flox (A) and Tsc1cKO (B) mice with antibodies against myelin basic protein (MBP; green; A,A’,B,B’) and pan-Neurofilament (NFL, red, A’,B’). White arrows indicate axons lacking MBP immunostaining surrounding axonal NFL (red). (C,D) Immunostaining of differentiated oligodendrocyte progenitor cell (OPC) cultures derived from P15 Tsc1Flox (C,C’,C”,C”’) and Tsc1cKO (D,D’,D”,D”’) mice, with antibodies again MBP (green) and Cnpase (red). DAPI was used as the labeling for nuclei. (E,F) Western blot analysis of MBP, myelin-associated glycoprotein (MAG) and PDGFRa proteins in SC (E) and MBP, MAG and P0 in sciatic nerves (F) from P15 Tsc1Flox and Tsc1cKO mice. β-actin was used as loading control. (G) Quantification of immunoblots shown in (E,F), *p < 0.05, or **p < 0.01. (H) RT-qPCR analysis of key differentiation genes in SCs from P15 Tsc1Flox (green) and Tsc1cKO (red) mice. Comparisons between genotypes were performed by Student t-test. n = 5, *p < 0.5. Scale bar: (A–E) = 2 μm.